92 related articles for article (PubMed ID: 14746888)
1. Potentiation of mitogenesis in adult rat chromaffin cell cultures by immunosuppressive agent FK506.
Powers JF; Brachold JM; Schelling K; Tischler AS
Neurosci Lett; 2004 Feb; 356(1):5-8. PubMed ID: 14746888
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells.
Shiraishi S; Yanagita T; Kobayashi H; Uezono Y; Yokoo H; Minami SI; Takasaki M; Wada A
J Pharmacol Exp Ther; 2001 May; 297(2):657-65. PubMed ID: 11303055
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells.
Satoh S; Yanagita T; Maruta T; Nemoto T; Yoshikawa N; Kobayashi H; Tono T; Wada A
Neuropharmacology; 2008 Jul; 55(1):71-9. PubMed ID: 18538359
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of FK506 and cyclosporin A on catecholamine release from bovine adrenal chromaffin cells.
Matsumura C; Kuwashima H; Kimura T
Auton Autacoid Pharmacol; 2004 Jul; 24(3):55-61. PubMed ID: 15541012
[TBL] [Abstract][Full Text] [Related]
5. Discordant effects of rapamycin on proliferation and p70S6 kinase phosphorylation in normal and neoplastic rat chromaffin cells.
Powers JF; Tischler AS; Cherington V
Neurosci Lett; 1999 Jan; 259(3):137-40. PubMed ID: 10025577
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin-independent inhibition of the delayed rectifier K+ current by the immunosuppressant FK506 in rat hippocampal neurons.
Yu Y; Chen XQ; Cui YY; Hu GY
Brain Res; 2007 May; 1148():62-8. PubMed ID: 17355875
[TBL] [Abstract][Full Text] [Related]
7. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control.
Furuke K; Nakamura H; Hori T; Iwata S; Maekawa N; Inamoto T; Yamaoka Y; Yodoi J
Int Immunol; 1995 Jun; 7(6):985-93. PubMed ID: 7577807
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic and antimitogenic effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in adult rat chromaffin cell cultures.
Tischler AS; Riseberg JC; Gray R
Neurosci Lett; 1995 Apr; 189(3):135-8. PubMed ID: 7624029
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin.
Richter A; Davies DE; Alexander P
Biochem Pharmacol; 1995 Jan; 49(3):367-73. PubMed ID: 7531976
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context.
Siemann G; Blume R; Grapentin D; Oetjen E; Schwaninger M; Knepel W
Mol Pharmacol; 1999 Jun; 55(6):1094-100. PubMed ID: 10347253
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel immunosuppressive agent, FK506, on human B cell activation.
Suzuki N; Sakane T; Tsunematsu T
Clin Exp Immunol; 1990 Feb; 79(2):240-5. PubMed ID: 1690097
[TBL] [Abstract][Full Text] [Related]
12. Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats.
Cui Q; Hodgetts SI; Hu Y; Luo JM; Harvey AR
Neuroscience; 2007 May; 146(3):986-99. PubMed ID: 17408862
[TBL] [Abstract][Full Text] [Related]
13. Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes.
Fujii Y; Fujii S; Kaneko T
Transplantation; 1989 Jun; 47(6):1081-3. PubMed ID: 2472025
[No Abstract] [Full Text] [Related]
14. Post-translational reduction of cell surface expression of insulin receptors by cyclosporin A, FK506 and rapamycin in bovine adrenal chromaffin cells.
Shiraishi S; Yokoo H; Kobayashi H; Yanagita T; Uezono Y; Minami S; Takasaki M; Wada A
Neurosci Lett; 2000 Nov; 293(3):211-5. PubMed ID: 11036198
[TBL] [Abstract][Full Text] [Related]
15. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
Sawada S; Suzuki G; Kawase Y; Takaku F
J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
[TBL] [Abstract][Full Text] [Related]
16. Role of basic FGF and oxygen in control of proliferation, survival, and neuronal differentiation in carotid body chromaffin cells.
Nurse CA; Vollmer C
Dev Biol; 1997 Apr; 184(2):197-206. PubMed ID: 9133430
[TBL] [Abstract][Full Text] [Related]
17. FK506-binding protein (FKBP12) regulates ryanodine receptor-evoked Ca2+ release in colonic but not aortic smooth muscle.
MacMillan D; Currie S; McCarron JG
Cell Calcium; 2008 Jun; 43(6):539-49. PubMed ID: 17950843
[TBL] [Abstract][Full Text] [Related]
18. Immunophilin regulation of neurotransmitter release.
Steiner JP; Dawson TM; Fotuhi M; Snyder SH
Mol Med; 1996 May; 2(3):325-33. PubMed ID: 8784785
[TBL] [Abstract][Full Text] [Related]
19. FK506, a Ca2+/calmodulin-dependent phosphatase inhibitor, inhibits the induction of long-term potentiation in the rat hippocampus.
Lu YF; Hayashi Y; Moriwaki A; Tomizawa K; Matsui H
Neurosci Lett; 1996 Feb; 205(2):103-6. PubMed ID: 8907327
[TBL] [Abstract][Full Text] [Related]
20. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
Wicker LS; Boltz RC; Matt V; Nichols EA; Peterson LB; Sigal NH
Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
